Ryan Widau, PhD, is a Senior Director and Clinical Research Scientist at Eli Lilly and Company, focusing on early phase oncology drug development. Since 2024, Ryan has specialized in precision medicine and GU oncology, applying expertise gained from previous roles within the company, including Director and Clinical Research Scientist. Prior to joining Eli Lilly, Ryan completed a postdoctoral fellowship at The University of Chicago, where they led a team in radiation and cellular oncology research. Ryan earned a Doctor of Philosophy (PhD) from the Indiana University School of Medicine in 2010.
This person is not in the org chart
This person is not in any teams
This person is not in any offices